LAVAL, QC, Oct. 15 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB), is pleased to announce the appointment of a dynamic new Scientific Advisory Board (the "Advisory Board"), comprised of 5 renowned scientists.
Neptune believes that the combined knowledge and experience of the new members of the Advisory Board will significantly contribute to Neptune's scientifically driven growth. Neptune feels privileged to build its new Scientific Advisory Board with a group of such distinguished scientists.
a. Steven E. Nissen, M.D., MACC, is the Chairman of the Cleveland Clinic
Department of Cardiovascular Medicine, and Immediate Past President,
American College of Cardiology, Washington, DC. He previously served
as the Medical Director of the Clinic's Cardiovascular Coordinating
Center. Dr. Nissen has stipulated that he receive no personal
compensation for participation in the Advisory Board and that any
consulting fees be paid directly to charity.
b. Magdy M. Abdel-Malik, Ph.D., is the president of Quaestio Global
Partners LLC (Quaestio GP), as the Director, Global External
Opportunities, Pfizer Consumer Healthcare, Morris Plains, NJ.
Dr. Abdel-Malik identified and secured external products and
technologies achieving above-market growth for the $4B Pfizer Consumer
c. Thomas G. Hartman, Ph.D. has served for the past 22 years as Mass
Spectrometry Lab Manager at the Rutgers University Center for Advanced
Food Technology (CAFT). Dr. Hartman has served as an analytical and
technical consultant to over 250 companies and many government
agencies. He is a member of the American Society of Mass Spectrometry
(ASMS), American Chemical Society (ACS) and the Agricultural and Food
Chemistry Division, American Association for the Adva
|SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.|
Copyright©2007 PR Newswire.
All rights reserved